Sequencing of Treatment in MM (Multiple Myeloma)

Introduction

Multiple myeloma (MM) is a haematological malignancy characterised by the clonal expansion of malignant plasma cells in the bone marrow. MM manifests clinically as hypercalcaemia, renal failure, anaemia and bone lesions (known as CRAB features), and is most common in people aged over 65 years. MM affects around 361 people in Ireland each year, 1 and despite advancements in treatments remains incurable in 2022.